Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3ANTARES PHARMA INC

02 8ASSERTIO SPECLTY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

02

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

03

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

TESTOSTERONE ENANTHATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 209863

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

04

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

05

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

06

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

07

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

08

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

09

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank

10

arrow
BePharma
Not Confirmed
arrow
BePharma
Not Confirmed

METHOTREXATE

US Patent Number : 11446441

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204824

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-01-24

blank